Comparison of Sacubitril/Valsartan Versus Enalapril in the Management of Heart Failure

Background and objective The recent emergence of new molecules like angiotensin receptor-neprilysin inhibitor (ARNI) has highlighted the need for an update in heart failure (HF) management, as they have proven to yield better patient outcomes compared to the traditional angiotensin-converting enzyme...

Descripción completa

Detalles Bibliográficos
Autores principales: Bano, Shehar, Bai, Pooja, Kumar, Sameet, Kumar, Nomesh, Ali, Ahmed, Pariya, FNU, Versha, FNU, Khalid, Dua, Khalid, Haya, Rizwan, Amber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357012/
https://www.ncbi.nlm.nih.gov/pubmed/34395116
http://dx.doi.org/10.7759/cureus.16332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357012/
https://www.ncbi.nlm.nih.gov/pubmed/34395116
http://dx.doi.org/10.7759/cureus.16332

Ejemplares similares